ConductScience.org, home

Paper40902196

Molecular Docking and Target-Specific Binding Profiles of Benzosuberane-Based Compounds.

Saragatsis MA and 3 others. ChemMedChem, 2025. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Molecular Docking and Target-Specific Binding Profiles of Benzosuberane-Based Compounds. Papers, record 40902196. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40902196

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Molecular Docking and Target-Specific Binding Profiles of Benzosuberane-Based Compounds.
PubMed
Journal
ChemMedChem
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2026-09-25
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Saragatsis MAMichail Ahttps://orcid.org/0009-0002-8462-5376
2Kinsella GKGemma K
3Curtin JFJames F
4Zhang TTaohttps://orcid.org/0000-0003-1079-5364

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Molecular Docking SimulationMajor topic
Antineoplastic AgentsMajor topic
NeoplasmsMajor topic
Humans
Cell Proliferation
Molecular Structure
Structure-Activity Relationship

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
PB04565Technological University DublinPubMed

Source PubMed

Download CSV of grants

References107

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131417185MAPKAPK2 (MK2) inhibition mediates radiation-induced inflammatory cytokine production and tumor growth in head and neck squamous cell carcinoma.Oncogene2019https://conductscience.org/library/papers/31417185PubMed
222114500A polymeric colchicinoid prodrug with reduced toxicity and improved efficacy for vascular disruption in cancer therapy.Int J Nanomedicine2011https://conductscience.org/library/papers/22114500PubMed
328383176Insight into the remarkable affinity and selectivity of the aminobenzosuberone scaffold for the M1 aminopeptidases family based on structure analysis.Proteins2017https://conductscience.org/library/papers/28383176PubMed
435890113Synthesis, Structure−Activity Relationships, and Parasitological Profiling of Brussonol Derivatives as New Plasmodium falciparum InhibitorsPharmaceuticals (Basel)2022https://conductscience.org/library/papers/35890113PubMed
529455642Role and targeting of anaplastic lymphoma kinase in cancer.Mol Cancer2018https://conductscience.org/library/papers/29455642PubMed
634483651Machine Learning and Deep Learning Based Computational Approaches in Automatic Microorganisms Image Recognition: Methodologies, Challenges, and Developments.Arch Comput Methods Eng2022https://conductscience.org/library/papers/34483651PubMed
731592646Dual Inhibitors of Human DNA Topoisomerase II and Other Cancer-Related Targets.J Med Chem2020https://conductscience.org/library/papers/31592646PubMed
814716737Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer.Prostate2004https://conductscience.org/library/papers/14716737PubMed
925618350Small-molecule library screening by docking with PyRx.Methods Mol Biol2015https://conductscience.org/library/papers/25618350PubMed
1032183020The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer.Int J Mol Sci2020https://conductscience.org/library/papers/32183020PubMed
1125625291Targeting cyclin-dependent kinases in human cancers: from small molecules to Peptide inhibitors.Cancers (Basel)2015https://conductscience.org/library/papers/25625291PubMed
1222564207Discovery of an orally efficacious inhibitor of anaplastic lymphoma kinase.J Med Chem2012https://conductscience.org/library/papers/22564207PubMed
1334278794AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings.J Chem Inf Model2021https://conductscience.org/library/papers/34278794PubMed
1426529257Myo9b is a key player in SLIT/ROBO-mediated lung tumor suppression.J Clin Invest2015https://conductscience.org/library/papers/26529257PubMed
1512925999Detailed analysis of grid-based molecular docking: A case study of CDOCKER-A CHARMm-based MD docking algorithm.J Comput Chem2003https://conductscience.org/library/papers/12925999PubMed
1628934959Selective inhibition of PfA-M1, over PfA-M17, by an amino-benzosuberone derivative blocks malaria parasites development in vitro and in vivo.Malar J2017https://conductscience.org/library/papers/28934959PubMed
1731784318Development and structure-activity relationship study of SHP2 inhibitor containing 3,4,6-trihydroxy-5-oxo-5H-benzo[7]annulene.Bioorg Med Chem Lett2020https://conductscience.org/library/papers/31784318PubMed
1824349632Role of p38 MAP Kinase Signal Transduction in Solid Tumors.Genes Cancer2013https://conductscience.org/library/papers/24349632PubMed
1921321746A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment.Integr Biol (Camb)2011https://conductscience.org/library/papers/21321746PubMed
2036058118Novel 6,7,8-trihydrobenzo[6',7']cyclohepta[2',1'-e]pyrazolo[2,3-a]pyrimidine derivatives as Topo IIα inhibitors with potential cytotoxic activity.Bioorg Chem2022https://conductscience.org/library/papers/36058118PubMed

See all 107 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42655636Human Coronavirus Photodynamic Inactivation and In Silico Mechanisms Induced by Ga(III) vs. Zn(II) Phthalocyanines.Viruses2026https://conductscience.org/library/papers/42655636PubMed
42458892Recent Overview on the Molecular Hybrids Integrated With Benzosuberone/Benzo[7]annulene Derivatives as Multi-Target Therapeutics.Arch Pharm (Weinheim)2026https://conductscience.org/library/papers/42458892PubMed
41821758A comparison of honeybee and scorpion venoms as anticancer agents against three different cancer cell lines: lung, colon, and breast cancer.Front Toxicol2026https://conductscience.org/library/papers/41821758PubMed
40902196Molecular Docking and Target-Specific Binding Profiles of Benzosuberane-Based Compounds.ChemMedChem2025https://conductscience.org/library/papers/40902196PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40902196

GET https://conductscience.org/api/papers/v1/40902196/references?page=2